Clinical outcomes in psoriatic arthritis: A systematic literature review - Wikidata - wikimedia - TriplyDB

Clinical outcomes in psoriatic arthritis: A systematic literature review

Clinical outcomes in psoriatic arthritis: A systematic literature review

http://www.wikidata.org/entity/Q26995307

about

Making the next steps in psoriatic arthritis management: current status and future directions International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA).Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set Psoriatic arthritis: an evolving matter.Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.Patient involvement in outcome measures for psoriatic arthritis.Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis.Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study.Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.It's not just the joints, it's the whole thing: qualitative analysis of patients' experience of flare in psoriatic arthritis.Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.

P2860

Q26783506-C67785F1-B6BD-4A98-AFA6-9A5182828CF2 Q30841346-2618BBF6-0CA3-495B-9A4C-136A441D5AA8 Q34228353-4480685C-AF06-4D38-876D-3786FFA2FA90 Q35372388-6E341490-4B27-403E-B751-B96A354A1718 Q35953575-B8B612BF-5127-4B47-BA9A-F1E75C46CCAB Q36182379-B09AB287-A1A8-4E11-BA04-2627F99AC686 Q36183841-F469228A-7947-45FC-A576-D637FA58FCD5 Q37520856-81762306-C607-454F-AB3E-A6496D4EAE52 Q37585837-1A7A7D51-6C36-487A-A2C8-CD21301BF23D Q38195568-4EFAE72A-58B9-4DB3-B7FC-164C14503147 Q38667430-11E53247-27C9-4152-A1D5-DD12FA30B32C Q38947002-F5C4C611-B2CD-4200-8A5B-8C2687BDAD87 Q39114063-A2C4DBCD-F698-4EF1-A030-67EF3C19FCF0 Q41266305-4E3A6CCB-B017-4C8F-94D6-058846D194D8 Q47782073-3FBB2AD6-8F48-4F71-AE11-A48E024C58EF Q53090514-36292CB9-4074-4D8C-8969-FB6906B47738 Q54443616-0503AAD4-8C86-4827-A0EB-ADC01777651D

P2860

Clinical outcomes in psoriatic arthritis: A systematic literature review

http://www.wikidata.org/entity/Q26995307

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical outcomes in psoriatic arthritis: A systematic literature review

@ast

Clinical outcomes in psoriatic arthritis: A systematic literature review

@en

Clinical outcomes in psoriatic arthritis: A systematic literature review

@nl

type

label

Clinical outcomes in psoriatic arthritis: A systematic literature review

@ast

Clinical outcomes in psoriatic arthritis: A systematic literature review

@en

Clinical outcomes in psoriatic arthritis: A systematic literature review

@nl

prefLabel

Clinical outcomes in psoriatic arthritis: A systematic literature review

@ast

Clinical outcomes in psoriatic arthritis: A systematic literature review

@en

Clinical outcomes in psoriatic arthritis: A systematic literature review

@nl

P1433

Q26995307-7CC5A16A-EE81-440C-BE29-5FC59E502F90

P1476

Q26995307-B15C8B6F-EDE2-4205-BC8C-73BBB3A854F4

P2093

Q26995307-A0738CE5-13AB-4DED-AEB1-E2F19E3F9F8C

P2860

Q26995307-00C87D1C-3C0D-4E1B-9111-00DBCE9F54F7

Q26995307-03A99DAB-2E0C-46DC-AC4F-74D9896FAAB4

Q26995307-064F1D11-EF5A-406C-8F65-C82028A29EA3

Q26995307-0FFBD147-105A-413F-B0F0-844992906A62

Q26995307-104B006D-4E5A-4CA2-BE27-65836F2EE275

Q26995307-1B0B16D3-F914-41B5-89F5-BD0A9E1D91FD

Q26995307-1F374413-3BFA-4EB1-AFD6-0C2D8D9BABE7

Q26995307-204F16C7-A05E-484E-918F-E7C920F06C56

Q26995307-241BA828-2292-4473-B901-23FCF7E47C8D

Q26995307-257298AB-2F85-473C-B616-7BCC8E6C6DCA

P304

Q26995307-E0916AF0-568E-4244-95FC-86D77560EF74

P31

Q26995307-187BCF72-246D-48A7-A345-A6571781E824

P356

Q26995307-D9F053DC-B5D0-4B72-ADC6-18905EFA47B3

P407

Q26995307-8DFDBB66-47C7-4E24-84D2-1B72515D6C5F

P433

Q26995307-5A5348AE-4301-4FE8-AD33-40C4091BB424

P478

Q26995307-B23FD466-F74B-4FDA-9DC2-0B35C6008460

P50

Q26995307-39F7400E-C90B-4C95-A1F9-84BDEC77D0EA

Q26995307-46303D7A-F7AE-4854-B831-301AE1614002

Q26995307-B3190895-DACF-4262-9B38-97FBFCEA0396

Q26995307-E1A38E8B-1CEE-4702-8D91-53F9876F66A4

P577

Q26995307-9B2AA05A-4ACF-488D-B0DA-0A87AC699BC5

P5875

Q26995307-048AA70D-7CED-4454-BD70-E516E8FF4791

P698

Q26995307-6CE5E8CC-8DCC-4337-A41F-AAFC84FFA8F0

P356

P1433

Arthritis Care and Research

P1476

Clinical outcomes in psoriatic arthritis: A systematic literature review

@en

P2093

Penélope Esther Palominos

http://www.w3.org/2001/XMLSchema#string

P2860

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

EuroQol--a new facility for the measurement of health-related quality of life

Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

P304

397-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.21552

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Cécile Gaujoux-Viala

Maxime Dougados

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51858246

http://www.w3.org/2001/XMLSchema#string

P698

22147535

http://www.w3.org/2001/XMLSchema#string